Find a Trial

Trial Summary


Protocol No.CTO-IUSCC-0723
StatusOPEN TO ACCRUAL
Principal InvestigatorHanna, Nasser
ScopeLocal
PhaseNA
Age GroupAdult
TitleEvaluating the incidence and outcomes of patients with stage III non-small cell lung cancer (NSCLC) whose tumors harbor STK11 and/or Keap1 mutations treated with chemoradiation (CRT) followed by consolidation immunotherapy
Applicable Disease SitesLung
Participating InstitutionsIndiana University (IU)
    Treatment TypeBasic Science
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu